The biosimilars industry has become a vital pillar in the global healthcare ecosystem, offering highly comparable alternatives to biologic therapies at a reduced cost. As the burden of chronic diseases such as cancer, autoimmune disorders, and diabetes continues to rise, healthcare systems are increasingly focused on delivering affordable and effective treatment options.  Market Overview...